Founded in August 2022, Malama Health is dedicated to providing HIPAA-compliant remote monitoring for diabetes in pregnancy, a condition affecting nearly 1 in 5 women. The company's mission is to lower C-section and preterm birth rates by simplifying the tracking of glucose and meal data for both patients and healthcare providers. Malama's core product is a free app that offers holistic support through pregnancy and postpartum, enabling personalized care and seamless communication with healthcare providers. Their market focus includes hospitals and healthcare systems, with initial partnerships including Stanford Hospital and Santa Clara Valley Medical.

Malama Health is backed by notable investors such as Y Combinator and has affiliations with prestigious institutions like Stanford. Key achievements include signing five pilot partners within two weeks of launch and establishing a pipeline of 30 additional potential partners. Mika, who previously led clinical product innovation at UnitedHealthcare, brings significant expertise to the team. Malama's impact lies in its potential to improve maternal health outcomes by leveraging technology to provide accessible and efficient diabetes management during pregnancy.